Today: 9 June 2026
Browse Category

TSX:8604 8 December 2025 - 23 April 2026

Sensex, Nifty Fall Again Today as Oil Holds Above $100 and HSBC Cuts India to Underweight

Sensex, Nifty Fall Again Today as Oil Holds Above $100 and HSBC Cuts India to Underweight

Indian stocks fell Thursday, with the Nifty 50 at 24,207.25 and Sensex at 77,799.23 by early afternoon, as Brent crude stayed above $100 and HSBC downgraded Indian equities to “underweight.” The rupee dropped to a three-week low past 94 per dollar. Foreign investors have pulled $4.3 billion from Indian shares in April. Pharma shares rose, but financials and automakers led declines.
23 April 2026
······
Bitcoin Price Today: BTC Holds $70,000 as ETF Inflows Clash With Oil Shock

Bitcoin Price Today: BTC Holds $70,000 as ETF Inflows Clash With Oil Shock

Bitcoin held above $70,000 on Thursday, last trading at $70,323, down 0.7% after touching $69,240. U.S.-listed spot bitcoin ETFs took in $115.2 million Wednesday, with BlackRock’s IBIT accounting for most inflows. Brent crude briefly topped $101, and Wall Street fell amid Middle East tensions. Economists expect the first Fed rate cut in June, but futures markets now point to September.
12 March 2026
····
Silver price today: Spot jumps above $80 as haven demand returns ahead of U.S. inflation data

Silver price today: Spot jumps above $80 as haven demand returns ahead of U.S. inflation data

Spot silver rose 2.8% to $80.57 an ounce in early European trading Friday, hitting a new high as investors reacted to U.S.-Iran tensions and falling bond yields. Gold gained 0.7% to $5,032.49. Solar panel makers reported surging costs, with U.S. silver-paste prices for modules more than tripling since early 2025. Markets await U.S. inflation and GDP data due at 13:30 GMT.
20 February 2026
···

Stock Market Today

  • NSE Allocates 10% of Annual CSR Fund to Social Stock Exchange
    June 9, 2026, 10:16 AM EDT. The National Stock Exchange (NSE) will deploy 10% of its annual Corporate Social Responsibility (CSR) corpus through the Social Stock Exchange, signaling trust in this market-based platform designed to connect social enterprises with investors. This move aims to enhance transparency and impact investing by leveraging the exchange's resources to support social causes.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Go toTop